DigiPath

Wichita, United States Founded: 2010 • Age: 16 yrs
Digital pathology solutions for clinicians

About DigiPath

DigiPath is a Healthcare company based in Wichita (United States) founded in 2010. Digital pathology solutions for clinicians. DigiPath has raised $10.4 million across 2 funding rounds. Its focus areas include HealthTech, Clinical Labs IT, Pathology and Image Analysis. Its legal entity is Digipath Inc. Its competitors include Viz.ai, PathAI and Deepcell; 3 of its 3 listed competitors have raised funding.

Company details

DigiPath was founded in 2010 and is based in Wichita, United States. Operations focus on the digital pathology sector within healthcare technology. Solutions for clinicians include PathScope, utilized as a whole slide imaging system, and Pathlive, employed for real-time telepathology. PathReview functions as a web-based viewer and image server management tool, supporting annotation, measurement, and conferencing features for digital slides.

  • Headquarters Wichita, United States
  • Sectors
    Healthcare
  • Website digipath.biz
  • Social LinkedIn X
  • Legal Name Digipath Inc
Key Metrics
  • Total Equity Funding
    $10.4M (USD)

    in 2 rounds

  • Latest Funding Round
    $8.2M (USD), Private Equity Round

    Jul 2014

Funding Insights of DigiPath

DigiPath has successfully raised a total of $10.4M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $8.2 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10.4M
  • Total Rounds 2
  • Last Round Private Equity Round β€” $8.2M
  • First Round $2.2M

    (May 2014)

All 2 funding rounds of DigiPath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2014$8.2MPrivate Equity Round––
–
May 2014$2.2MPrivate Equity Round––
–

Timeline of DigiPath

3 dated milestones of DigiPath across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded DigiPath is founded.
  2. Funding First funding round of $2.2M.
  3. Funding Latest funding round, Private Equity Round, of $8.2M.

Competitors of DigiPath

DigiPath has 3 listed competitors in our database, 3 of them funded. They include Viz.ai, PathAI and Deepcell.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viz.ai2016San Francisco, United States$251.99M206
AI and cloud-powered software for stroke care coordination is developed.
pathai.com2016Boston, United States$254.94M573
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
deepcell.com2015Mountain View, United States$122.99M94
AI-powered single cell classification and isolation technology for clinical research
Premium access

Detailed competitors of DigiPath

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as DigiPath (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DigiPath

DigiPath was founded in 2010 and raised its 1st funding round 4 years after it was founded.

DigiPath is headquartered in Wichita, United States. It is registered at Wichita, Kansas, United States.

DigiPath is a funded company, having raised a total of $10.4M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $2.2M, raised on May 2014.

DigiPath was founded in 2010 and is based in Wichita, United States. Operations focus on the digital pathology sector within healthcare technology. Solutions for clinicians include PathScope, utilized as a whole slide imaging system, and Pathlive, employed for real-time telepathology. PathReview functions as a web-based viewer and image server management tool, supporting annotation, measurement, and conferencing features for digital slides.

DigiPath's top competitors include PathAI, Viz.ai and Deepcell.

DigiPath operates through Digipath Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available